These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Non-pneumonia lower respiratory infection by Neisseria meningitidis]. Legaria MC; Chadarevian M; Regueira M; Corso A; Hoffman M Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):508-9. PubMed ID: 9011216 [No Abstract] [Full Text] [Related]
6. Carrier rate of Neisseria meningitidis and the occurrence of sulfonamide resistant strains in Lebanon. Uwaydah M J Med Liban; 1973; 26(5):495-500. PubMed ID: 4205464 [No Abstract] [Full Text] [Related]
7. Neisseria meningitidis nasopharynx colonization of diseased patients on presentation and on discharge. Barroso D Trop Doct; 1999 Apr; 29(2):108-9. PubMed ID: 10418306 [TBL] [Abstract][Full Text] [Related]
8. [Obtaining of erythrocytic diagnostic agent for indirect hemagglutination reaction in meningococcal infection]. Polianin VA Lab Delo; 1974; 7(9):426-8. PubMed ID: 4139346 [No Abstract] [Full Text] [Related]
9. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state. Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiological and laboratory criteria in the assessment of meningococcus carrier state]. Demina AA; PokrovskiÄ VI; Kuz'menko SV; Deviatkina NP; Larina LI Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):79-85. PubMed ID: 64094 [TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population. Kaiser AB; Hennekens CH; Saslaw MS; Hayes PS; Bennett JV J Infect Dis; 1974 Sep; 130(3):217-24. PubMed ID: 4213375 [No Abstract] [Full Text] [Related]
13. Human immunity to the meningococcus. II. Development of natural immunity. Goldschneider I; Gotschlich EC; Artenstein MS J Exp Med; 1969 Jun; 129(6):1327-48. PubMed ID: 4977281 [TBL] [Abstract][Full Text] [Related]
14. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. Gotschlich EC; Goldschneider I; Artenstein MS J Exp Med; 1969 Jun; 129(6):1385-95. PubMed ID: 4977284 [TBL] [Abstract][Full Text] [Related]
15. [Immunoepidemiological characteristics of the duration of a meningococcal carrier state]. Deviatkina NP; Demina AA; Koroleva IS Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):99-102. PubMed ID: 6240875 [TBL] [Abstract][Full Text] [Related]
16. [Dynamic observation of the epidemic process in meningococcal infection in a unit]. Perepelkin VS; Polianin VA Voen Med Zh; 1984 Oct; (10):35-7. PubMed ID: 6438903 [No Abstract] [Full Text] [Related]
17. [Antibody response in subjects with meningococal disease and in healthy carriers of Neisseria meningitidis]. Natoli D; Tringali G; Puma G; Castellini S; Chiarini A G Batteriol Virol Immunol; 1976; 69(1-6):64-70. PubMed ID: 828887 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of group A and group C meningococcal polysaccharides in human infants. Goldschneider I; Lepow ML; Gotschlich EC; Mauck FT; Bachl F; Randolph M J Infect Dis; 1973 Dec; 128(6):769-76. PubMed ID: 4203078 [No Abstract] [Full Text] [Related]